Rare diseases
Investigational molecules
Locations
Forum Apres-Demain, Chemin Messidor 5-7, 1006
Debiopharm International S.A. supports clinical studies in advanced solid tumors, with activity spanning biomarker-selected disease settings and difficult-to-treat malignancies. Its research includes uterine serous carcinoma, high-grade epithelial ovarian cancer, and other molecularly selected cancers linked to alterations such as CCNE1 amplification and FBXW7-related changes.
The sponsor also funds studies in small cell lung cancer and advanced prostate cancer, reflecting a strong interest in malignancies with limited treatment options.
Debiopharm International SA runs clinical trials in conditions such as Acromegaly, Neoplasm, Glioblastoma, Prostate cancer metastatic, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Austria
Denmark
Spain
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
